Physician profile
Scott Bornstein
NPI 1609866433
$2,979.27
in general payments reported to CMS, 2019-2025
20 companies · $566 in 2025
The $566 reported for 2025 was more than what 81% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $767 · 2021: $239 · 2022: $409 · 2023: $496 · 2024: $317 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,378.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,378.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,152.55 | 2019-2025 | Argos, Rocklatan, Clareon |
| Novartis Pharmaceuticals Corporation | $273.33 | 2019-2023 | |
| Thea Pharma INC. | $190.33 | 2022-2025 | Iyuzeh |
| Bausch & Lomb Americas INC. | $184.99 | 2022-2025 | Stellaris, Envista Mx60 Iol, Envista Envy Iol |
| Amgen INC. | $172.78 | 2024-2025 | Tepezza |
| Alexion Pharmaceuticals, INC. | $170.66 | 2019-2024 | Ultomiris, Soliris |
| Sun Pharmaceutical Industries INC. | $166.12 | 2022-2024 | Cequa |
| Abbvie INC. | $162.90 | 2022-2024 | Alphagan P, Lumigan, Vuity |
| Allergan, INC. | $80.94 | 2019-2021 | |
| Horizon Therapeutics Plc | $67.10 | 2019-2023 | Tepezza |
| Harrow Eye, LLC | $54.11 | 2024 | Vevye |
| Oyster Point Pharma, INC. | $43.54 | 2023 | Tyrvaya |
| Aerie Pharmaceuticals, INC. | $41.35 | 2021 | |
| Akorn Operating Company LLC | $40.71 | 2021 | |
| Biotissue Holdings INC. | $39.59 | 2019-2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $34.61 | 2025 | Xdemvy |
| Alimera Sciences, INC. | $32.04 | 2024 | Iluvien, Yutiq |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $30.96 | 2019-2020 | |
| Ocular Therapeutix, INC. | $23.81 | 2022 | |
| Tearlab Corp | $16.85 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Bornstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.